Active substance
Umifenovir hydrochloride (umifenovir)
Release form, composition and packaging
◊ Film-coated tablets from white to white with a creamy tint, round, biconvex; on the fracture - from white to white with a greenish-yellowish or creamy tint.
Excipients: potato starch - 31.86 mg, microcrystalline cellulose - 57.926 mg, (povidone K30) - 8.137 mg, calcium stearate - 0.535 mg, croscarmellose (croscarmellose sodium) - 1.542 mg.
Shell composition: hypromellose (hydroxypropyl methylcellulose) - 4.225 mg, titanium dioxide - 1.207 mg, macrogol (polyethylene glycol 4000) - 0.471 mg, polysorbate 80 (Tween 80) - 0.097 mg; or Aquarius PrimeBAP318008 White - 6 mg [hypromellose (hydroxypropyl methylcellulose) - 4.225 mg, titanium dioxide - 1.207 mg, macrogol (polyethylene glycol 4000) - 0.471 mg, polysorbate 80 (Tween 80) - 0.097 mg].
10 pieces. - contour cell packaging (1) - cardboard packs.
10 pieces. - contour cell packaging (2) - cardboard packs.
10 pieces. - contour cell packaging (3) - cardboard packs.
10 pieces. - contour cell packaging (4) - cardboard packs.
pharmachologic effect
Antiviral drug. Specifically suppresses in vitro influenza viruses A and B (Influenza virus A, B), including highly pathogenic subtypes A(H1N1)pdm09 and A(H5N1), as well as other viruses that cause acute respiratory viral infections (coronavirus associated with severe acute respiratory syndrome (SARS), rhinovirus (Rhinovirus), adenovirus (Adenovirus), respiratory syncytial virus (Pneumovirus) and parainfluenza virus (Paramyxovirus)). According to the mechanism of antiviral action, it belongs to fusion inhibitors, interacts with the hemagglutinin of the virus and prevents the fusion of the lipid membrane of the virus and cell membranes. It has a moderate immunomodulatory effect and increases the body's resistance to viral infections. It has interferon-inducing activity - in a study on mice, induction was noted after 16 hours, and high titers interferons remained in the blood for up to 48 hours after administration. Stimulates cellular and humoral immune responses: increases the number of lymphocytes in the blood, especially T-cells (CD3), increases the number of T-helper cells (CD4) without affecting the level of T-suppressors (CD8), normalizes the immunoregulatory index, stimulates the phagocytic function of macrophages and increases the number of natural killer (NK) cells.
Therapeutic effectiveness for viral infections is manifested in a decrease in the duration and severity of the disease and its main symptoms, as well as in a decrease in the incidence of complications associated with viral infection, and exacerbations of chronic bacterial diseases.
Refers to low-toxic drugs (LD 50 >4 g/kg). Does not have any negative effects on the human body when administered orally in recommended doses.
Pharmacokinetics
Suction and distribution
Quickly absorbed and distributed throughout organs and tissues. Cmax in the blood when taken at a dose of 50 mg is achieved after 1.2 hours, at a dose of 100 mg - after 1.5 hours.
Metabolism and excretion
Metabolized in the liver.
T1/2 is 17-21 hours. About 40% is excreted unchanged, mainly with bile (38.9%) and in small amounts by the kidneys (0.12%). During the first day, 90% of the administered dose is eliminated.
Indications
Contraindications
- hypersensitivity to umifenovir or any component of the drug;
- children under 3 years of age;
- I trimester of pregnancy;
- breastfeeding period.
Dosage
The drug is taken orally, before meals.
Single dose (depending on age):
| Indication | Dosage regimen |
| In children over 3 years of age and adults: | |
| Nonspecific prevention during an epidemic of influenza and other acute respiratory viral infections | in a single dose 2 times a week for 3 weeks. |
| Nonspecific prophylaxis in direct contact with patients with influenza and other acute respiratory viral infections | in a single dose 1 time/day for 10-14 days. |
| Treatment of influenza and other acute respiratory viral infections | |
| In children from 3 years of age: | |
| Complex therapy of acute intestinal infections rotavirus etiology | in a single dose 4 times/day (every 6 hours) for 5 days. |
| In children over 3 years of age and adults: | |
| Complex therapy chronic bronchitis, pneumonia, herpetic infection | in a single dose 4 times a day (every 6 hours) for 5-7 days, then single dose 2 times a week for 4 weeks |
| Prevention of postoperative infectious complications | in a single dose 2 days before surgery, then on days 2 and 5 after surgery |
The drug should be taken from the moment the first symptoms of influenza and other acute respiratory viral infections appear, preferably no later than 3 days from the onset of the disease.
If after taking the drug for 3 days during the treatment of influenza and other acute respiratory viral infections, the severity of the symptoms of the disease persists, incl. heat(38°C or more), the patient should consult a doctor to assess the validity of taking the drug.
The drug should be used only according to the indications, the method of administration and in the doses indicated in the instructions.
Side effects
Arbidol is a low-toxic drug and is usually well tolerated. Side effects occur rarely, are usually mild or moderate and are transient.
The incidence of adverse drug reactions is determined in accordance with the WHO classification: very often (>1/10), often (≥1/100, but<1/10), нечасто (≥1/1000, но <1/100), редко (≥1/10 000, но <1/1000), очень редко (<1/10 000), частота неизвестна (не может быть установлена по имеющимся данным).
From the immune system: rarely - allergic reactions.
If any of the side effects indicated in the instructions are aggravated or any other side effects not specified in the instructions are noted, the patient should inform the doctor.
When treating influenza and ARVI, concomitant symptomatic therapy is possible, including taking antipyretic drugs, mucolytics and local vasoconstrictors.
Overdose
There have been no cases of drug overdose.
Drug interactions
When prescribed with other drugs, no negative effects were noted.
No special clinical studies have been conducted to study the interaction of the drug Arbidol with other drugs.
There was no evidence of undesirable interactions with antipyretic, mucolytic and local vasoconstrictor drugs in a clinical study.
special instructions
If after taking the drug Arbidol for 3 days during the treatment of influenza and other acute respiratory viral infections, the severity of the symptoms of the disease persists, incl. high temperature (38°C or more), then you need to consult a doctor to assess the validity of taking the drug.
Impact on the ability to drive vehicles and operate machinery
It does not exhibit central neurotropic activity and can be used in medical practice by people of various professions that require increased attention and coordination of movements (including transport drivers, operators).
Pregnancy and lactation
In animal studies, no harmful effects on pregnancy, embryonic and fetal development, labor or postnatal development were identified.
The use of Arbidol in the first trimester of pregnancy is contraindicated.
In the second and third trimesters of pregnancy, Arbidol can be used only for the treatment and prevention of influenza and if the expected benefit to the mother outweighs the potential risk to the fetus. The benefit/risk ratio is determined by the attending physician.
It is not known whether Arbidol is excreted in breast milk in women during lactation. If it is necessary to use the drug Arbidol, breastfeeding should be stopped.
Use in childhood
The drug is contraindicated for use in children under 3 years of age.
Conditions for dispensing from pharmacies
The drug is available without a prescription.
Storage conditions and periods
The drug should be stored out of the reach of children at a temperature not exceeding 25°C. Shelf life - 3 years. Do not use after the expiration date stated on the package.
In this article you can read the instructions for use of the drug Arbidol. Reviews of site visitors - consumers of this medicine, as well as the opinions of specialist doctors on the use of Arbidol in their practice are presented. We kindly ask you to actively add your reviews about the drug: whether the medicine helped or did not help get rid of the disease, what complications and side effects were observed, perhaps not stated by the manufacturer in the annotation. Analogues of Arbidol in the presence of existing structural analogues. Use for the treatment of influenza, bronchitis, pneumonia and other colds and acute respiratory infections in adults, children, as well as during pregnancy and lactation.
Arbidol- antiviral drug. Specifically suppresses influenza A and B viruses, SARS-associated coronavirus. According to the mechanism of antiviral action, it belongs to fusion inhibitors, interacts with the hemagglutinin of the virus and prevents the fusion of the lipid membrane of the virus and cell membranes.
Has a moderate immunomodulatory effect.
It has interferon-inducing activity, stimulates humoral and cellular immune responses, the phagocytic function of macrophages, and increases the body's resistance to viral infections.
Reduces the incidence of complications associated with viral infection, as well as exacerbations of chronic bacterial diseases.
Therapeutic effectiveness for viral infections is manifested in a decrease in the severity of general intoxication and clinical phenomena, and a reduction in the duration of the disease.
Refers to low-toxic drugs. Does not have any negative effects on the human body when administered orally in recommended doses.
Pharmacokinetics
After oral administration, it is quickly absorbed from the gastrointestinal tract. Metabolized in the liver. About 40% is excreted unchanged, mainly with bile (38.9%) and in small quantities by the kidneys (0.12%). During the first day, 90% of the dose taken is eliminated.
Indications for use
Prevention and treatment in adults and children:
- influenza A and B, ARVI, SARS, incl. complicated by bronchitis and pneumonia;
- secondary immunodeficiency states;
- complex therapy of chronic bronchitis, pneumonia and recurrent herpes infection.
Prevention of postoperative infectious complications and normalization of immune status.
As part of complex therapy of acute intestinal infections of rotavirus etiology in children over 3 years of age.
Release forms
Tablets 50 mg, 100 mg
Capsules 50mg, 100mg
Instructions for use and dosage regimen
For nonspecific prophylaxis
In direct contact with a patient with influenza and other acute respiratory viral infections, adults and children over 12 years of age are prescribed Arbidol at a dose of 200 mg per day; children aged 6 to 12 years - 100 mg per day; children aged 3 to 6 years - 50 mg per day. The drug is taken 1 time per day. Course - 10-14 days.
During an epidemic of influenza and other acute respiratory viral infections, to prevent exacerbation of chronic bronchitis and relapse of herpes infection, adults and children over 12 years of age are prescribed the drug in a single dose of 200 mg; children aged 6 to 12 years - 100 mg; children aged 3 to 6 years - 50 mg. The drug is taken 2 times a week for 3 weeks.
To prevent SARS (in contact with a patient), adults and children over 12 years of age are prescribed 200 mg once a day for 12-14 days; children aged 6 to 12 years - 100 mg 1 time per day (before meals) for 12-14 days.
To prevent postoperative infectious complications, the drug is prescribed two days before surgery, then on the second and fifth days after surgery in doses: adults and children over 12 years old - 200 mg, children aged 6 to 12 years - 100 mg, from 3 to 6 years - 50 mg.
For treatment
For influenza and other acute respiratory viral infections without complications, adults and children over 12 years of age are prescribed the drug 200 mg 4 times a day (every 6 hours), children aged 6 to 12 years - 100 mg 4 times a day (every 6 hours), from 3 to 6 years - 50 mg 4 times a day (every 6 hours). The course of treatment is 5 days.
For influenza and other acute respiratory viral infections with the development of complications (including bronchitis, pneumonia), adults and children over 12 years of age are prescribed Arbidol 200 mg 4 times a day (every 6 hours) for 5 days, then 200 mg 1 time per week for 4 weeks. Children aged 6 to 12 years are prescribed 100 mg 4 times a day (every 6 hours), then 100 mg once a week for 4 weeks. Children aged 3 to 6 years are prescribed 50 mg 4 times a day (every 6 hours) for 5 days, then 50 mg once a week for 4 weeks.
For the treatment of SARS, adults and children over 12 years of age are prescribed 200 mg 2 times a day for 8-10 days.
As part of complex therapy for chronic bronchitis and recurrent herpetic infections in adults and children over 12 years of age, the drug is prescribed 200 mg 4 times a day (every 6 hours) for 5-7 days, then 200 mg 2 times a week for 4 weeks . Children aged 6 to 12 years: 100 mg 4 times a day (every 6 hours) for 5-7 days, then 100 mg 2 times a week for 4 weeks. Children aged 3 to 6 years are prescribed 50 mg 4 times a day (every 6 hours) for 5-7 days; then - 50 mg 2 times a week for 4 weeks.
As part of complex therapy for acute intestinal infections of rotavirus etiology, children over 12 years of age are prescribed 200 mg 4 times a day (every 6 hours) for 5 days, for children aged 6 to 12 years - 100 mg 4 times a day (every 6 hours). ) for 5 days, at the age of 3 to 6 years - 50 mg 4 times a day (every 6 hours) for 5 days.
Side effect
- allergic reactions.
Contraindications
- children under 3 years of age;
- hypersensitivity to the components of the drug.
Use during pregnancy and breastfeeding
Data on the use of Arbidol during pregnancy and breastfeeding are not provided. That is, taking the drug in these cases is undesirable, since the evidence base and justification for taking it are not provided by the manufacturer of the drug.
Impact on the ability to drive vehicles and operate machinery
The drug does not exhibit central neurotropic activity and can be used in medical practice for preventive purposes in practically healthy individuals of various professions that require increased attention and speed of psychomotor reactions (including transport drivers, operators).
Analogues of the drug Arbidol
Structural analogues of the active substance:
- Arpetol
- Arpetolide
- Arpeflu
- ARVItol
If there are no analogues of the drug for the active substance, you can follow the links below to the diseases for which the corresponding drug helps, and look at the available analogues for the therapeutic effect.
LSR-003900/07
Trade name of the drug:
Arbidol ®
International nonproprietary name
Umifenovir.
Chemical name: Ethyl 6-bromo-5-hydroxy-1-methyl-4-dimethylaminomethyl-2-phenylthiomethylindole-3-carboxylic acid hydrochloride monohydrate.
Dosage form:
film-coated tablets.
Description
Film-coated tablets from white to white with a creamy tint, round, biconvex. On the fracture it is white to white with a greenish-yellowish or creamy tint.
Composition per tablet
Active substance: umifenovir (umifenovir hydrochloride monohydrate (arbidol) in terms of umifenovir hydrochloride) - 50 mg or 100 mg.
Excipients:
core: potato starch - 31.860 mg or 63.720 mg; microcrystalline cellulose - 57.926 mg or 115.852 mg; povidone-K30 (kollidon 30) - 8.137 mg or 16.274 mg; calcium stearate - 0.535 mg or 1.070 mg; croscarmellose sodium (primellose) - 1.542 mg or 3.084 mg.
shell: hypromellose (hydroxypropyl methylcellulose) - 4.225 mg or 8.450 mg; titanium dioxide - 1.207 mg or 2.415 mg; macrogol-4000 (polyethylene glycol-4000) - 0.471 mg or 0.942 mg; polysorbate-80 (Tween-80) - 0.097 mg or 0.193 mg (for dosages of 50 mg and 100 mg) or AdvantiaTMPrime 390035ZP01 (AdvantiaTMPrime 390035ZP01) - 6 mg [Hypromellose (hydroxypropyl methylcellulose), titanium dioxide, macrogol-4000 (polyethylene lenglycol-4000) , polysorbate-80 (Tween-80)] - for a dosage of 50 mg.
Pharmacotherapeutic group:
antiviral agent.
ATX code: .
Pharmacological properties
Pharmacodynamics. Antiviral agent. Specifically suppresses influenza A and B viruses, coronavirus associated with severe acute respiratory syndrome (SARS). According to the mechanism of antiviral action, it belongs to fusion inhibitors, interacts with the hemagglutinin of the virus and prevents the fusion of the lipid membrane of the virus and cell membranes. Has a moderate immunomodulatory effect. It has interferon-inducing activity, stimulates humoral and cellular immune responses, the phagocytic function of macrophages, and increases the body's resistance to viral infections. Reduces the incidence of complications associated with viral infection, as well as exacerbations of chronic bacterial diseases.
Therapeutic effectiveness for viral infections is manifested in a decrease in the severity of general intoxication and clinical phenomena, a reduction in the duration of the disease, and a decrease in the risk of complications.
Refers to low-toxic drugs (LD50 >4 g/kg). Does not have any negative effects on the human body when administered orally in recommended doses.
Pharmacokinetics. Quickly absorbed and distributed throughout organs and tissues. The maximum concentration in blood plasma when taken at a dose of 50 mg is achieved after 1.2 hours, at a dose of 100 mg - after 1.5 hours. Metabolized in the liver. The half-life is 17 - 21 hours. About 40% is excreted unchanged, mainly with bile (38.9%) and in small amounts by the kidneys (0.12%). During the first day, 90% of the administered dose is eliminated.
Indications for use
Prevention and treatment in adults and children:
- influenza A and B, ARVI, severe acute respiratory syndrome (SARS) (including those complicated by bronchitis, pneumonia);
- secondary immunodeficiency states;
- complex therapy of chronic bronchitis, pneumonia and recurrent herpes infection.
Prevention of postoperative infectious complications and normalization of immune status.
Complex therapy of acute intestinal infections of rotavirus etiology in children over 3 years of age.
Contraindications
Hypersensitivity to the drug, children under 3 years of age.
Directions for use and doses
Inside, before meals. Single dose: children from 3 to 6 years old - 50 mg, from 6 to 12 years old - 100 mg, over 12 years old and adults - 200 mg (2 tablets of 100 mg or 4 tablets of 50 mg).
For nonspecific prophylaxis:
- in direct contact with patients with influenza and other acute respiratory viral infections:
children from 3 to 6 years old - 50 mg, from 6 to 12 years old - 100 mg, over 12 years old and adults - 200 mg 1 time per day for 10-14 days;
- during an epidemic of influenza and other acute respiratory viral infections, to prevent exacerbations of chronic bronchitis, relapse of herpes infection:
children from 3 to 6 years old - 50 mg, from 6 to 12 years old - 100 mg, over 12 years old and adults - 200 mg 2 times a week for 3 weeks.
- for the prevention of SARS (in contact with a patient):
adults and children over 12 years of age are prescribed 200 mg once a day for 12-14 days.
- prevention of postoperative complications:
children from 3 to 6 years old - 50 mg, from 6 to 12 years old - 100 mg, over 12 years old and adults - 200 mg 2 days before surgery, then 2-5 days after surgery.
For treatment:
- influenza, other acute respiratory viral infections without complications:
children from 3 to 6 years old - 50 mg, from 6 to 12 years old - 100 mg, over 12 years old and adults - 200 mg 4 times a day (every 6 hours) for 5 days;
- influenza, other acute respiratory viral infections with the development of complications (bronchitis, pneumonia, etc.):
children from 3 to 6 years old - 50 mg, from 6 to 12 years old - 100 mg, over 12 years old and adults - 200 mg 4 times a day (every 6 hours) for 5 days, then a single dose 1 time per week for 4 weeks.
Severe acute respiratory syndrome (SARS):
adults and children over 12 years old - 200 mg 2 times a day for 8-10 days.
In the complex treatment of chronic bronchitis, herpetic infection:
children from 3 to 6 years old - 50 mg, from 6 to 12 years old - 100 mg, over 12 years old and adults - 200 mg 4 times a day (every 6 hours) for 5-7 days, then a single dose 2 times a week within 4 weeks.
Complex therapy of acute intestinal infections of rotavirus etiology in children over 3 years of age:
from 3 to 6 years - 50 mg, from 6 to 12 years - 100 mg, over 12 years - 200 mg 4 times a day (every 6 hours) for 5 days.
Side effect
Rarely - allergic reactions.
Overdose
Not marked.
Interaction with other drugs
When prescribed with other drugs, no negative effects were noted.
special instructions
It does not exhibit central neurotropic activity and can be used in medical practice for preventive purposes in practically healthy individuals of various professions, incl. requiring increased attention and coordination of movements (transport drivers, operators, etc.).
Release form
Film-coated tablets 50 mg, 100 mg.
10 tablets in a blister pack.
10, 20, 30 or 40 tablets in a polymer jar.
1, 2, 3 or 4 blister packs or a polymer jar of 10, 20, 30 or 40 tablets along with instructions for use in a cardboard pack.
Best before date
2 years. Do not use after the expiration date stated on the package.
Storage conditions
At a temperature not higher than 25 °C.
Keep out of the reach of children.
Conditions for dispensing from pharmacies
Without a doctor's prescription.
Name and address of the manufacturer / company accepting consumer complaints:
PJSC "Pharmstandard-Tomskkhimpharm", 634009, Russia, Tomsk, Lenin Ave., 211.
Antiviral, immunostimulating. Treatment and prevention of influenza and other acute respiratory viral infections, chronic bronchitis, pneumonia, recurrent herpes infection, for the prevention of infectious complications and normalization of immune status. Orally, before meals. One dose: children 2-6 years old - 0.05g, 6-12 years old - 0.1g, over 12 years old and adults - 0.2g 3 times a day. For prevention - 1 time a day.
Antiviral drug. Specifically suppresses influenza A and B viruses, coronavirus associated with severe acute respiratory syndrome (SARS). According to the mechanism of antiviral action, it belongs to fusion inhibitors, interacts with the hemagglutinin of the virus and prevents the fusion of the lipid membrane of the virus and cell membranes. Has a moderate immunomodulatory effect. It has interferon-inducing activity, stimulates humoral and cellular immune responses, the phagocytic function of macrophages, and increases the body's resistance to viral infections. Reduces the incidence of complications associated with viral infection, as well as exacerbations of chronic bacterial diseases. Therapeutic effectiveness for viral infections is manifested in a decrease in the severity of general intoxication and clinical phenomena, a reduction in the duration of the disease, and a decrease in the risk of complications. Refers to low-toxic drugs (LD50 >4 g/kg). Does not have any negative effects on the human body when administered orally in recommended doses.
Prevention and treatment in adults and children: - influenza A and B, ARVI, severe acute respiratory syndrome (SARS) (including those complicated by bronchitis, pneumonia); — secondary immunodeficiency states; - complex therapy of chronic bronchitis, pneumonia and recurrent herpes infection. Complex therapy of acute intestinal infections of rotavirus etiology in children over 3 years of age. Prevention of postoperative infectious complications and normalization of immune status.
The drug is taken orally before meals. Single dose: - 50 mg, children aged 6 to 12 years- 100 mg, children over 12 years old and adults- 200 mg (2 tablets of 100 mg or 4 tablets of 50 mg). Nonspecific prevention At direct contact with patients with influenza and other acute respiratory viral infections children aged 3 to 6 years Prescribe 50 mg, - 100 mg, - 200 mg 1 time / day for 10-14 days. During epidemics of influenza and other acute respiratory viral infections, to prevent exacerbations of chronic bronchitis, relapse of herpes infection appoint children aged 3 to 6 years- 50 mg, children aged 6 to 12 years- 100 mg, children over 12 years old and adults- 200 mg 2 times a week for 3 weeks. For SARS prevention (in contact with a patient) prescribed 200 mg 1 time/day for 12-14 days. For prevention of postoperative complications appoint children aged 3 to 6 years- 50 mg, children aged 6 to 12 years- 100 mg, children over 12 years old and adults- 200 mg 2 days before surgery, then 2-5 days after surgery. Treatment At uncomplicated course of influenza and other acute respiratory viral infections:children aged 3 to 6 years- 50 mg, children aged 6 to 12 years- 100 mg, children over 12 years old and adults- 200 mg 4 times/day (every 6 hours) for 5 days; For treatment of influenza, other acute respiratory viral infections with the development of complications (bronchitis, pneumonia)children aged 3 to 6 years 50 mg is prescribed children aged 6 to 12 years- 100 mg, children over 12 years old and adults- 200 mg 4 times/day (every 6 hours) for 5 days, then a single dose is prescribed once a week for 4 weeks. Severe acute respiratory syndrome (SARS): adults and children over 12 years old- 200 mg 2 times/day for 8-10 days. Complex therapy of chronic bronchitis, herpetic infection: children aged 3 to 6 years- 50 mg, children aged 6 to 12 years- 100 mg, children over 12 years old and adults- 200 mg 4 times a day (every 6 hours) for 5-7 days, then a single dose is prescribed 2 times a week for 4 weeks. Complex therapy of acute intestinal infections of rotavirus etiology in children over 3 years of age:children aged 3 to 6 years- 50 mg, children aged 6 to 12 years- 100 mg, children over 12 years old- 200 mg 4 times/day (every 6 hours) for 5 days.
Rarely: allergic reactions.
- children under 3 years of age; - hypersensitivity to the drug.
Children are more susceptible to viral diseases. The likelihood of developing the disease increases when a child begins to attend kindergarten or school. In addition, viral infections appear in young patients during the cold season or during epidemics. This is due to the fact that the baby’s body continues to develop, and the immune system weakens during the off-season. It is important to treat the child correctly to prevent complications. For this purpose, it is recommended to use Arbidol at the first symptoms of the disease.
An effective drug that demonstrates an antiviral effect is called Arbidol. Most often it is used for influenza and respiratory diseases. In addition, the medication helps prevent viral infections during epidemics. Arbidol strengthens the immune system and exhibits antioxidant protection. The drug is available in various dosage forms and is well tolerated by patients.
Composition and effect on the body
Arbidol for children is available in tablets, capsules and powder. As a rule, children are prescribed tablets to treat viral diseases. Although the amount of active substance in capsules and pills is the same. However, the second dosage form is more convenient for young patients. But if the child is already old enough, then he can take capsules. The main thing is to follow the dosage prescribed by the pediatrician.
The suspension looks like a cream-colored powder, which is diluted with water before use. This syrup is allowed to be taken by patients over 2 years of age. The main component of the drug is umifenovir. In addition, the medicine contains additional substances: MCC, pyrogenic silicon dioxide, starch, calcium sterol, povidone, etc.
To understand how Arbidol works, you need to start from the moment the child becomes infected. When the virus enters the body, it provokes the production of hemagglutinin (a special protein). With its help, the pathogenic agent attaches to receptors on the surface of cells, causing inflammatory reactions. With influenza and acute respiratory infections, the pathogenic microorganism affects the respiratory tract and ENT organs.
Viruses multiply in the body, causing inflammation to grow. As a result, the patient develops a cough, rhinitis, swelling of the mucous membranes, and a sore throat. Arbidol blocks the production of hemagglutinin, which damages body tissue. That is, the drug protects cells from the action of a pathogenic agent, keeping it on the outer shell until its life cycle ends. As a rule, after 3–4 days the virus dies.
Arbidol helps prevent influenza or acute respiratory infections during mass illnesses. The therapeutic effect is due to the fact that the medication blocks the action of the pathogenic microorganism immediately after it penetrates the internal membranes. The drug is prescribed to children when the body's immune strength is reduced.
Thus, Arbidol demonstrates the following effects:
- antiviral;
- immunomodulatory;
- antioxidant;
- detoxification;
- reduces the likelihood of complications from viral infections.
In addition, with timely and regular use of Arbidol, chronic diseases are less likely to worsen.
Appointment of Arbidol
The drug treatment regimen is determined by the pediatrician, taking into account age and clinical picture.
Arbidol is prescribed to children if they have the following diseases:
- Influenza (type A, B), respiratory diseases.
- Viral infections that are accompanied by inflammation of the bronchi and lungs.
- After surgery, to reduce the likelihood of viruses entering the body.
- Diseases of viral etiology with a chronic course (to reduce the frequency of exacerbations of the disease).
According to the instructions for use, Arbidol helps not only to cure, but also to prevent viral infections.
Tablet dosage
A single dose of medication for patients of different ages:
- 3 – 6 years – 50 mg;
- 7 – 12 years – 100 mg;
- from 13 years – 200 mg.
Tablets are sold with different dosages of umifenovir - 50 or 100 mg. Your doctor will help you choose the appropriate concentration for your child.
Arbidol treatment regimens for different diagnoses:
- For the prevention of influenza, acute respiratory infections - a single dose, treatment lasts 10 - 14 days.
- To prevent viral infections during mass diseases - a standard portion for 20 days.
- For flu or mild colds - 4 single doses per 24 hours for 5 days.
- For influenza or acute respiratory infections with complications, a single dose is taken four times a day for 5 days. Then take 1 tablet every 7 days for 1 month.
The final dosage of the medicine for children will be determined by the pediatrician.
Application of capsules
A single dose of the drug in capsule form for children is no different. Patients from 3 to 6 years old take 1 piece with a concentration of umifenovir 50 mg, children from 7 to 12 years old - 1 capsule of 100 mg, and patients over 13 years old - 2 capsules of 100 mg.
Treatment regimens for diseases of viral origin:
- For flu and colds, children over 3 years old drink 1 capsule four times, over 7 years old - 1 capsule (100 mg), over 13 years old - 2 pieces (100 mg each) with the same frequency of use. Treatment lasts 5 days.
- To cure influenza, acute respiratory infections with complications need to take a standard dose four times a day for 5 days. Then 1 dose of the medicine is taken 1 time every 7 days for 1 month.
- To prevent viral infections, children are prescribed 1 serving of capsules twice every 7 days. The total duration of therapy is 3 weeks.
If the child has been in contact with a sick person, then a single dose is taken once every 14 days.
Suspension for children
The suspension is sold in pharmacies less frequently than other dosage forms. The finished syrup is stored on the bottom shelf of the refrigerator for no longer than 10 days. After this period, the medicine must not be used. Patients over 2 years old can use the solution for medical reasons.
To prepare the syrup, pour 30 ml of warm water into the bottle with the powder after boiling. Then you need to close the lid and shake the liquid so that the contents dissolve. Then pour a little more water into the bottle so that its level reaches 100 ml, close it and shake again. After this procedure, the suspension is ready.
A single dose depends on the age of the child:
- 2 – 6 years – 10 ml;
- 7 – 12 years – 20 ml;
- from 13 years – 40 ml.
The solution is taken according to the following scheme:
- To prevent colds - a single dose twice every 7 days. Duration of treatment – 20 days.
- To prevent viral infections after contact with a patient - 1 dose within 14 days.
- To cure the flu, acute respiratory infections - a single serving four times. Therapy lasts 5 days.
The final dose of the medicine will be determined by the pediatrician, taking into account the age and individual characteristics of the child’s body.
Restrictions and contraindications
Arbidol is well tolerated by children and rarely provokes negative reactions. The drug in the form of tablets and capsules is prohibited for use by patients under three years of age (including up to one year). The suspension is not recommended for children under 2 years of age. In addition, Arbidol is contraindicated in case of intolerance to its components.
In case of renal, hepatic, cardiac or vascular failure, the child can take Arbidol, but his condition must be monitored by a pediatrician. If the rules of use are violated or there are contraindications, a rash on the skin, itching, nettle fever, and nausea appear. If such symptoms appear, stop taking Arbidol and consult your doctor.
Cost of the drug
You can find Arbidol in all pharmacies in the country; its cost depends on the dosage form and volume:
- Powder for making syrup (25 ml) costs from 330 to 350 rubles.
- Pills (50 mg) 10 pcs. - on average 150 rubles.
- The cost of 100 mg tablets (the same quantity) is 190 rubles.
- For 10 capsules (50 mg) you need to pay 180 rubles.
- Gelatin-coated pills (100 mg) 10 pcs. cost about 240 rubles.
If necessary, Arbidol can be replaced with a cheaper medicine with a similar effect.
Alternative medicines
If there are contraindications, the child is given drugs with a similar therapeutic effect. Popular analogues of Arbidol for children:
- Ingavirin helps fight influenza viruses (type A, B). This medicine is more effective than Arbidol, but has more side effects, so before using it you must obtain the approval of a pediatrician.
- used for the prevention and treatment of viral infections. Stimulates the production of interferon and helps the body fight pathogenic agents. Designed for children over 3 years old.
- Aflubin is another analogue of Arbidol, which provokes the synthesis of interferon. After taking the drug, the swelling of the mucous membrane decreases, the removal of sputum accelerates, the temperature normalizes, and the body is cleansed of toxins. For patients up to 12 months, a suspension is used.
- Remantadine does not strengthen the immune system, but it copes well with viruses. The medication is contraindicated in children with liver failure and patients younger than 12 months.
- is a homeopathic medicine for the prevention and treatment of influenza and colds. With regular use, the likelihood of dangerous complications (bronchitis, pneumonia) decreases.
- Immunal increases immunity, prevents viral diseases, and accelerates recovery in the presence of infection. The drug is contraindicated only if you are allergic to its components. Suitable for patients up to 12 months.
Thus, Arbidol for children is an effective and, subject to treatment rules, a safe drug. Before using it, consult your pediatrician, who will select a treatment regimen and dosage. If a child experiences side effects after taking Arbidol, stop taking it and consult a doctor.
